The Abnormal Expressions of c-erbB-2 or p53 Proteins are Significant Prognostic Factors in Gastric Cancer

Yoshihiko Maehara, Hisao Oiwa, Liu Qi, Tatsuo Oshiro, Toshiro Okuyama, Yoshiro Kakeji, Hiroyuki Orita, Shinji Ohno, Hideo Baba, Yosuke Adachi, Keizo Sugimachi

Research output: Contribution to journalArticlepeer-review

Abstract

We evaluated the expression of the c-erbB-2 protein and the abnormal p53 protein gastric cancer, using monoclonal antibodies mAb 1 and PAb 240, respectively. c-rebB-2 protein expression was found in 17 (11%) of 160 gastric cancers. The 5-year survival rates in patients with positive and negative c-erbB-2 protein were 29% and 47%, respectively, a statistically significant difference. Moreover, patients with positive staining had higher recurrence rates, such as lymph node metastasis, hepatic metastasis and peritoneal dissemination. Abnormalities in p53 expression were found in 52 (54%) of 96 gastric cancers. Tumors stained positively for p53 metastasized to lymph nodes (Metastatic rate: 85%) more frequently than those with negative staining (64%). The incidence of DNA aneuploid pattern, as determined by flow cytometry, and proliferative activity, as measured by the Ki-67 labeling index, were higher in the p53-positive group than in the p53-negative group. Data on the immunohistochemistry of c-erbB-2 and p53 proteins in gastric cancer will be clinically useful in providing information on prognosis.

Original languageEnglish
Pages (from-to)2508-2511
Number of pages4
Journalthe japanese journal of gastroenterological surgery
Volume26
Issue number10
DOIs
Publication statusPublished - Feb 1 1993

All Science Journal Classification (ASJC) codes

  • Surgery
  • Gastroenterology

Fingerprint Dive into the research topics of 'The Abnormal Expressions of c-erbB-2 or p53 Proteins are Significant Prognostic Factors in Gastric Cancer'. Together they form a unique fingerprint.

Cite this